
DT&CRO CO., Ltd. — Investor Relations & Filings
DT&CRO CO., Ltd. is a full-service Contract Research Organization (CRO) that provides a comprehensive series of commissioned studies for the biopharmaceutical, chemical, functional food, and cosmetics sectors. The company's services span the entire development lifecycle, from non-clinical research, including GLP toxicity, pharmacokinetics (PK), and efficacy tests, to clinical trials, analysis, and regulatory consulting. Specialized offerings include a full-package service for FDA IND and NDA submissions, developed in partnership with Radyus Research. DT&CRO also provides an in-house SEND (Standard for Exchange of Nonclinical Data) program to streamline FDA registration and approval. Additionally, the company offers MoPS, a proprietary IT program that enables sponsors to manage projects and communicate with specialists in real-time.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [기재정정]분기보고서 (2026.03) | 2026-05-18 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| [기재정정]분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 정기주주총회결과 | 2026-03-30 | Korean | |
| 사업보고서 (2025.12) | 2026-03-20 | Korean | |
| 감사보고서제출 | 2026-03-20 | Korean |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46380143 | [기재정정]분기보고서 (2026.03) | 2026-05-18 | Korean | ||
| 46360456 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 46355014 | [기재정정]분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 33084944 | 정기주주총회결과 | 2026-03-30 | Korean | ||
| 32997631 | 사업보고서 (2025.12) | 2026-03-20 | Korean | ||
| 32996874 | 감사보고서제출 | 2026-03-20 | Korean | ||
| 32934821 | 주주총회소집공고 | 2026-03-12 | Korean | ||
| 32934791 | 의결권대리행사권유참고서류 | 2026-03-12 | Korean | ||
| 32933881 | 주주총회소집결의 | 2026-03-12 | Korean | ||
| 32933880 | 주주총회집중일개최사유신고 | 2026-03-12 | Korean | ||
| 32841500 | [기재정정]증권발행결과(자율공시) (제3회차) | 2026-02-26 | Korean | ||
| 32838378 | 주식등의대량보유상황보고서(약식) | 2026-02-26 | Korean | ||
| 32838340 | [기재정정]주요사항보고서(신주인수권부사채권발행결정) | 2026-02-26 | Korean | ||
| 32838339 | [기재정정]주요사항보고서(전환사채권발행결정) | 2026-02-26 | Korean | ||
| 32825869 | 전환사채(해외전환사채포함)발행후만기전사채취득 (제1회차) | 2026-02-23 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
DT&CRO CO., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15282/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15282 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15282 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15282 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15282}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for DT&CRO CO., Ltd. (id: 15282)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.